AzTrials
AzTrials

BoxingNCT07862166

Transcranial Direct Current Stimulation Promotes Punching and Movement Speed in Elite Male Boxers

A study testing Anodal tDCS over M1 and Anodal tDCS over DLPFC in people with Boxing and Athletic Performance, run by Beijing Sport University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study investigates whether transcranial direct current stimulation (tDCS), a safe and non-invasive brain stimulation technique, can improve punching and movement speed in elite male boxers. Read more about this study

Who is it for?
Ages 18 to 30 years, men onlyHealthy volunteers can take part
Conditions the study is for
Boxing, Athletic Performance, tDCS
What is being tested?
Anodal tDCS over M1 and Anodal tDCS over DLPFC
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
24 participants
Where
1 siteChina
Study dates
9 May 2024to 9 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male elite boxers (national level 1 or above)
  • Age 18-30 years
  • No personal or family history of epilepsy or psychosis
  • No medical device implants in the body
  • No sports injuries within the last 6 months
  • Normal vision or normal vision after correction
  • Not taking medications that alter central nervous system function

Who cannot join

  • Health status not meeting study requirements
  • Poor adherence to study requirements

Trial locations and contacts

1 site in 1 country.

China1 site
  • Beijing Sport University

    Beijing, Beijing Municipality, 100084

Other trials in China

About this study

This study investigates whether transcranial direct current stimulation (tDCS), a safe and non-invasive brain stimulation technique, can improve punching and movement speed in elite male boxers. Twenty-four elite male boxers will receive 2 mA tDCS over either the primary motor cortex (M1), the dorsolateral prefrontal cortex (DLPFC), or sham stimulation for 20 minutes, in a randomized, counterbalanced order. Punching speed and movement speed will be assessed before and at three time points after stimulation (immediately, 20 minutes, and 45 minutes). The study aims to determine whether tDCS can enhance boxing-specific performance and whether the effects differ between stimulation sites.

Read the detailed description

Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that modulates cortical excitability. Previous research suggests that tDCS over motor and prefrontal regions may enhance motor performance and cognitive function. However, its effects on sport-specific skills in elite athletes, particularly boxing, remain limited.

This study employed a single-blind, sham-controlled, within-subjects design. Twenty-four elite male boxers were recruited. Each participant completed four sessions: one familiarization session and three stimulation sessions (M1, DLPFC, and sham) in a randomized, counterbalanced order. The primary objectives were to investigate the effects of tDCS over M1 and DLPFC on punching speed (average reaction time and total punches) and movement speed (movement time) in elite male boxers. Secondary objectives included monitoring maximum heart rate and ratings of perceived exertion.

Being tested
Anodal tDCS over M1, Anodal tDCS over DLPFC, Sham tDCS
Keywords
boxing, elite boxer, reaction time, non-invasive brain stimulation, speed

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Anodal tDCS over M1Device

    A transcranial electrical stimulator (YINGCI TCS-E2, Shenzhen, China) delivered 2 mA anodal tDCS for 20 minutes. Saline-soaked (0.9% NaCl) surface sponges covered with conductive rubber electrodes served as the anode and cathode. The anode was positioned over C3-Cz-C4 (5 × 15 cm), and the cathode over the forehead medial above the nasion.

  • Anodal tDCS over DLPFCDevice

    A transcranial electrical stimulator (YINGCI TCS-E2, Shenzhen, China) delivered 2 mA anodal tDCS for 20 minutes. The anode was positioned over F3 (5 × 7 cm), targeting the left DLPFC, and the cathode over the contralateral supraorbital region.

  • Sham tDCSDevice

    Sham stimulation was delivered using the same device. Electrical current was applied only during the first 30 s and the last 30 s of the 20-minute session, mimicking the mild tingling sensation of active tDCS.

Study groups in NCT07862166
Study groupRoleWhat they receive
M1 tDCSExperimentalParticipants received 2 mA anodal tDCS over the primary motor cortex (M1) for 20 minutes. The anode was placed over C3-Cz-C4 (5 × 15 cm) and the cathode over the forehead medial above the nasion.
Receives: Device: Anodal tDCS over M1
DLPFC tDCSExperimentalParticipants received 2 mA anodal tDCS over the left dorsolateral prefrontal cortex (DLPFC) for 20 minutes. The anode was placed over F3 (5 × 7 cm) and the cathode over the contralateral supraorbital region.
Receives: Device: Anodal tDCS over DLPFC
Sham tDCSSham comparatorParticipants received sham tDCS. Electrical current was applied only during the first 30 s and the last 30 s of the 20-minute session, mimicking the mild tingling sensation of active tDCS.
Receives: Device: Sham tDCS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Average reaction time (ART)

    Average reaction time recorded during the 1-minute punching speed test.

    Measured: Baseline, immediately after stimulation (post 1), 20 minutes after stimulation (post 2), and 45 minutes after stimulation (post 3)

  2. Total punches (TP)

    Total number of punches delivered during the 1-minute punching speed test.

    Measured: Baseline, immediately after stimulation (post 1), 20 minutes after stimulation (post 2), and 45 minutes after stimulation (post 3)

  3. Movement time (MT)

    Time taken to complete the eight-direction movement speed test.

    Measured: Baseline, immediately after stimulation (post 1), 20 minutes after stimulation (post 2), and 45 minutes after stimulation (post 3)

Secondary outcomes (2)
  1. Maximum heart rate (MHR)

    Maximum heart rate recorded during the punching and movement speed tests.

    Measured: Baseline, immediately after stimulation (post 1), 20 minutes after stimulation (post 2), and 45 minutes after stimulation (post 3)

  2. Ratings of perceived exertion (RPE)

    Ratings of perceived exertion assessed using the Borg Scale (6-20).

    Measured: Baseline, immediately after stimulation (post 1), 20 minutes after stimulation (post 2), and 45 minutes after stimulation (post 3)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Oct 2026
  2. Study start9 May 2024
  3. Primary completion9 May 2025
  4. Study completion9 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Within-subjects, single-blind, sham-controlled, crossover design. All participants received all three stimulation conditions (M1, DLPFC, and sham) in a randomized, counterbalanced order, with each session separated by at least 7 days.
Masking
Single blind
Who is masked
Participant
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07862166
Sponsor's protocol ID
2024147H
Status last verified
Oct 2026
First submitted
2 Oct 2026
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

Questions about this trial

What is this clinical trial studying?

A study testing Anodal tDCS over M1 and Anodal tDCS over DLPFC in people with Boxing and Athletic Performance, run by Beijing Sport University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Average reaction time (ART) (time frame: Baseline, immediately after stimulation (post 1), 20 minutes after stimulation (post 2), and 45 minutes after stimulation (post 3)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in